Head to Head Survey: Chemed (CHE) versus New York Health Care (BBAL)

Chemed (NYSE:CHE) and New York Health Care (OTCMKTS:BBAL) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

Institutional and Insider Ownership

88.1% of Chemed shares are held by institutional investors. 4.9% of Chemed shares are held by insiders. Comparatively, 6.7% of New York Health Care shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Chemed and New York Health Care’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Chemed $1.67 billion 2.86 $98.17 million $5.36 55.46
New York Health Care N/A N/A N/A N/A N/A

Chemed has higher revenue and earnings than New York Health Care.


This table compares Chemed and New York Health Care’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chemed 11.73% 35.13% 20.40%
New York Health Care N/A N/A N/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for Chemed and New York Health Care, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemed 0 1 2 0 2.67
New York Health Care 0 0 0 0 N/A

Chemed presently has a consensus price target of $328.67, indicating a potential upside of 10.57%. Given Chemed’s higher possible upside, research analysts plainly believe Chemed is more favorable than New York Health Care.

Volatility & Risk

Chemed has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, New York Health Care has a beta of -1.43, meaning that its stock price is 243% less volatile than the S&P 500.


Chemed pays an annual dividend of $1.20 per share and has a dividend yield of 0.4%. New York Health Care does not pay a dividend. Chemed pays out 22.4% of its earnings in the form of a dividend. Chemed has increased its dividend for 9 consecutive years.


Chemed beats New York Health Care on 10 of the 12 factors compared between the two stocks.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio.

New York Health Care Company Profile

New York Health Care, Inc. operates as a home care services agency primarily in New York. The company offers various home care services, such as companionship services, homemaker/housekeeper staff, professional and practical nurses, home health aides, care givers, geriatric care, and dementia and alzheimer care services. It also provides insurance services. The company was founded in 1983 and is based in Valley Stream, New York.

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply